Skip to content
Review

Locus coeruleus abnormalities on neuromelanin-sensitive MRI in Parkinson’s disease: a systematic review and meta-analysis

Oct 2026 · Journal of Neurology · Vol 273 · 0 citations · 85 references
Medicine

TL;DR

LC NM-MRI shows group-level differences in PD, but LC-signal differences vary across settings, but these comparisons do not establish individual diagnostic accuracy.

View source

Similar papers

Review Open access Oct 2026

Neuromelanin-Sensitive MRI as a Marker of Clinical Severity and Disease Burden in Parkinson's Disease: A Systematic Review and Meta-analysis.

The neuropathology of Parkinson's disease (PD) is characterized in part by the degeneration of catecholaminergic neurons, particularly dopaminergic neurons in the substantia nigra pars compacta (SNpc) and noradrenergic neurons in the locus coeruleus (LC), yet no validated in vivo biomarker quantifies this process. Neur...

Rayo Akande, T. Kustermann, Š. Holiga et al. · 0 citations
Review Nov 2026

Diagnostic accuracy of Neuromelanin-sensitive MRI for Parkinson Disease: A systematic review and meta-analysis.

NM-MRI demonstrates high diagnostic accuracy for differentiating PD from healthy controls, with volumetric analysis of the substantia nigra offering a robust and reproducible imaging biomarker.

Elisa Carvalho Ferreira, Cláudia Figueredo Nascimento Salomão Santos, Iago Vinicius Maia Hezel et al. · 0 citations
Review Open access Oct 2026

Diagnostic performance and methodological heterogeneity of neuromelanin-sensitive MRI in Parkinson's disease: A systematic review and meta-analysis

Background Parkinson's disease (PD) diagnosis remains primarily clinical and is often delayed until substantial neurodegeneration has occurred. Neuromelanin-sensitive MRI (NM-MRI) assesses the integrity of neuromelanin-rich nuclei affected in PD, the substantia nigra pars compacta (SNpc) and locus coeruleus (LC), but i...

Rayo Akande, T. Kustermann, Š. Holiga et al. · 0 citations
Open access Oct 2026

Locus coeruleus intensity as a marker of early-stage Alzheimer’s disease: associations with plasma pTau 217 and memory

INTRODUCTION: The locus coeruleus (LC) is one of the earliest sites of Alzheimers disease (AD) pathophysiological changes. LC magnetic resonance imaging (MRI) intensity may reflect effects of AD pathophysiology on the LC, providing a biomarker of early-stage AD. This study examined relationships among MRI-derived LC in...

Melanie L. Quiring, Yu-Han Shuai, Wen-Hui Zhao et al. · 0 citations
Review Open access Oct 2026

Dorsolateral nigral hyperintensity for differentiating Parkinson’s disease from atypical Parkinsonian syndromes: a meta-analysis

Background: Parkinson’s disease (PD) is a progressive neurodegenerative disorder caused by the loss of dopaminergic neurons in the substantia nigra, leading to cardinal motor symptoms such as bradykinesia, rigidity, resting tremor, and postural instability. Differentiating idiopathic PD from atypical parkinsonian syndr...

A. L. N. Sampaio, Alessandro Vidal de Oliveira, Alec Peixoto Rabelo et al. · 0 citations
Oct 2026

Dissociable noradrenergic and cholinergic contributions to cognitive function in early Parkinson's disease: A free-water imaging study.

OBJECTIVE To distinguish the roles of the noradrenergic locus coeruleus (LC) and cholinergic systems (nucleus basalis of Meynert [NBM], pedunculopontine nucleus [PPN]) in early Parkinson's disease (PD) cognitive impairment using free-water imaging (FWf). METHODS FWf metrics were derived from the LC and cholinergic pa...

Xin Wang, Wen-Ting Liu, Wei-Liang Wang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.